Purpose-driven biomaterials research in liver-tissue engineering

Trends in Biotechnology

Volumn 29, Issue 3, 2011, Pages 110-118

  Ananthanarayanan, Abhishek ^a,b   Narmada, Balakrishnan Chakrapani ^a   Mo, Xuejun ^a,b   McMillian, Michael ^c   Yu, Hanry ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL SCAFFOLDS; BIOMEDICAL APPLICATIONS; CELL CONSTRUCTS; CELL SOURCES; CELL-BASED ASSAYS; COMPLEX STRUCTURE; COMPUTATIONAL MODEL; ENGRAFTMENT; HEPATOCYTES; IN-VITRO; IN-VIVO; LEVEL METHOD; LIVER REGENERATION; MICRO-SCALES; OPTIMAL INTEGRATION; RATIONAL DESIGN;

BIOLOGICAL MATERIALS; BIOMATERIALS; LIVER; SCAFFOLDS; STEM CELLS; TISSUE ENGINEERING;

CELL CULTURE;

BIOMATERIAL; TISSUE SCAFFOLD; XENOBIOTIC AGENT;

COMPUTER MODEL; CULTURE TECHNIQUE; ENGRAFTMENT; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER PARENCHYMA; LIVER REGENERATION; MEDICAL RESEARCH; MICROENVIRONMENT; MOLECULAR MODEL; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; STEM CELL; STRUCTURE ACTIVITY RELATION; TISSUE ENGINEERING; TOXICITY TESTING;

ANIMALS; BIOCOMPATIBLE MATERIALS; EMBRYONIC STEM CELLS; HEPATOCYTES; HUMANS; LIVER; LIVER REGENERATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79951678150     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2010.10.006     Document Type: Review

References (86)

1. Griffith L.G., et al. Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell Biol. 2006, 7:211-224.
2. MacNeil S. Progress and opportunities for tissue-engineered skin. Nature 2007, 445:874-880.
3. Sauer I.M., et al. Development of a hybrid liver support system. Ann. N. Y. Acad. Sci. 2001, 944:308-319.
4. Bruns H., et al. Injectable liver: a novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes. Tissue Eng. 2005, 11:1718-1726.
5. Hollister S.J. Porous scaffold design for tissue engineering. Nat. Mater. 2005, 4:518-524.
6. Roelandt P., et al. Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells. PLoS One 2010, 5:e12101.
7. Williams D.F. On the nature of biomaterials. Biomaterials 2009, 30:5897-5909.
8. Khademhosseini A., et al. Microengineered hydrogels for tissue engineering. Biomaterials 2007, 28:5087-5092.
9. Khademhosseini A., et al. Microscale technologies for tissue engineering and biology. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2480-2487.
10. Du Y., et al. Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9522-9527.
11. Tsuda Y., et al. Monodisperse cell-encapsulating peptide microgel beads for 3D cell culture. Langmuir 2010, 26:2645-2649.
12. Liu Tsang V., et al. Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels. FASEB J. 2007, 21:790-801.
13. Zhao D., et al. Dendrimer hydrazides as multivalent transient inter-cellular linkers. Biomaterials 2008, 29:3693-3702.
14. Yang J., et al. Cell sheet engineering: recreating tissues without biodegradable scaffolds. Biomaterials 2005, 26:6415-6422.
15. Ong S.M., et al. Transient inter-cellular polymeric linker. Biomaterials 2007, 28:3656-3667.
16. Mo X., et al. Rapid construction of mechanically- confined multi- cellular structures using dendrimeric intercellular linker. Biomaterials 2010, 31:7455-7467.
17. Ohashi K., et al. Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat. Med. 2007, 13:880-885.
18. Tsuda Y., et al. The use of patterned dual thermoresponsive surfaces for the collective recovery as co-cultured cell sheets. Biomaterials 2005, 26:1885-1893.
19. Makowka L., et al. Allogeneic and xenogeneic hepatocyte transplantation. Transplant Proc. 1981, 13:855-859.
20. Lagasse E., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000, 6:1229-1234.
21. Oh S.K., et al. Long-term microcarrier suspension cultures of human embryonic stem cells. Stem. Cell Res. 2009.
22. Takahashi K., et al. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
23. Si-Tayeb K., et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010, 51:297-305.
24. Liu T., et al. Hepatic differentiation of mouse embryonic stem cells in three-dimensional polymer scaffolds. Tissue Eng. Part A 2010, 16:1115-1122.
25. Rashid S.T., et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Invest. 2010.
26. Toh Y.C., et al. A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab. Chip. 2007, 7:302-309.
27. Zhang C., et al. Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments. Lab. Chip. 2009, 9:3185-3192.
28. Y.C.H. V.N Goral, O.N. Petzold, J.S. Clark, P.k. Yuen, R.A. Faris (2010) Perfusion based microfluidic device for 3D dynamic primary human hepatocyte culture in absence of biological or synthetic matrices or coagulants Micro Tas, pp. pp.
29. Hui E.E, et al. Micromechanical control of cell-cell interactions. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:5722-5726.
30. Khetani S.R., et al. Microscale culture of human liver cells for drug development. Nat. Biotechnol. 2008, 26:120-126.
31. Zhang S., et al. Microfabricated silicon nitride membranes for hepatocyte sandwich culture. Biomaterials 2008, 29:3993-4002.
32. Feng Z.Q., et al. Rat hepatocyte aggregate formation on discrete aligned nanofibers of type-I collagen-coated poly(L-lactic acid). Biomaterials 2010, 31:3604-3612.
33. Ghibaudo M., et al. Substrate topography induces a crossover from 2D to 3D behavior in fibroblast migration. Biophys. J. 2009, 97:357-368.
34. Smets F., et al. Cell transplantation in the treatment of liver diseases. Pediatr Transplant 2008, 12:6-13.
35. Kawashita Y., et al. Hepatic repopulation with stably transduced conditionally immortalized hepatocytes in the Gunn rat. J. Hepatol. 2008, 49:99-106.
36. Espejel S., et al. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J. Clin. Invest. 2010.
37. Kumashiro Y., et al. Enrichment of hepatocytes differentiated from mouse embryonic stem cells as a transplantable source. Transplantation 2005, 79:550-557.
38. Arkudas A., et al. Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts. Tissue Eng. 2007, 13:1549-1560.
39. Kneser U., et al. Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng. 2006, 12:1721-1731.
40. Kedem A., et al. Vascular endothelial growth factor-releasing scaffolds enhance vascularization and engraftment of hepatocytes transplanted on liver lobes. Tissue Eng. 2005, 11:715-722.
41. Kaihara S., et al. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng. 2000, 6:105-117.
42. Uygun B.E., et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat. Med. 2010, 16:814-820.
43. Ueki T., et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat. Med. 1999, 5:226-230.
44. Sato Y., et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 2008, 26:431-442.
45. Zhang W., et al. Cell-delivery therapeutics for liver regeneration. Adv. Drug Deliv. Rev. 2010, 62:814-826.
46. Nagata H., et al. Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology 2007, 132:321-329.
47. Makowka L., et al. Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation. Surgery 1980, 88:244-253.
48. Haridass D., et al. Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am. J. Pathol. 2009, 175:1483-1492.
49. Venkatraman L., et al. The steady States and dynamics of urokinase-mediated plasmin activation. Pac. Symp. Biocomput. 2010, 190-200.
50. Brophy C.M., et al. Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function. Hepatology 2009, 49:578-586.
51. Kienhuis A.S., et al. A sandwich-cultured rat hepatocyte system with increased metabolic competence evaluated by gene expression profiling. Toxicol. In Vitro 2007, 21:892-901.
52. Keum Y.S., et al. Induction of heme oxygenase-1 (HO-1) and NAD[P]H: quinone oxidoreductase 1 (NQO1) by a phenolic antioxidant, butylated hydroxyanisole (BHA) and its metabolite, tert-butylhydroquinone (tBHQ) in primary-cultured human and rat hepatocytes. Pharm. Res. 2006, 23:2586-2594.
53. Williams D.P Toxicophores: investigations in drug safety. Toxicology 2006, 226:1-11.
54. Obach R.S., et al. Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose. Chem. Res. Toxicol. 2008, 21:1814-1822.
55. Dykens J.A., et al. The significance of mitochondrial toxicity testing in drug development. Drug Discovery Today 2007, 12:777-785.
56. Seidle T., et al. Cross-Sector Review of Drivers and Available 3Rs Approaches for Acute Systemic Toxicity Testing. Toxicological Sciences 2010, 116:382-396.
57. Allen J.W., et al. In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol. Sci. 2005, 84:110-119.
58. Sivaraman A., et al. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr. Drug Metab. 2005, 6:569-591.
59. Chao P., et al. Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human. Biochem. Pharmacol. 2009, 78:625-632.
60. Du Y., et al. Identification and characterization of a novel prespheroid 3-dimensional hepatocyte monolayer on galactosylated substratum. Tissue Eng. 2007, 13:1455-1468.
61. Cosgrove B.D., et al. Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. Toxicol. Appl. Pharmacol. 2009, 237:317-330.
62. Dash A I.W., Hoffmaster K., Sevidal S., Kelly J., Obach R.S., Griffith L.G., Tannebaum S.R. Liver tissue engineering in the evaluation of drug safety. Expert Opinion on Drug Metabolism & Toxicology 2009, 5:1159-1174.
63. Ng S., et al. Improved hepatocyte excretory function by immediate presentation of polarity cues. Tissue Eng. 2006, 12:2181-2191.
64. Mee C.J., et al. Effect of cell polarization on hepatitis C virus entry. J. Virol. 2008, 82:461-470.
65. Harris H.J., et al. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J. Virol. 2008, 82:5007-5020.
66. Chong T.W., et al. Primary human hepatocytes in spheroid formation to study hepatitis C infection. J. Surg. Res. 2006, 130:52-57.
67. Ploss A., et al. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3141-3145.
68. Bissig K.D., et al. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J. Clin. Invest. 2010, 120:924-930.
69. Yang P.L., et al. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13825-13830.
70. Janakiraman V., et al. Experimental investigation and computational modeling of hydrodynamics in bifurcating microchannels. Biomedical Microdevices 2008, 10:355-365.
71. Southam A.D., et al. Metabolic changes in flatfish hepatic tumours revealed by NMR-based metabolomics and metabolic correlation networks. J. Proteome. Res. 2008, 7:5277-5285.
72. Flaim C.J., et al. An extracellular matrix microarray for probing cellular differentiation. Nat. Meth. 2005, 2:119-125.
73. Szczurek E., et al. Elucidating regulatory mechanisms downstream of a signaling pathway using informative experiments. Mol. Syst. Biol. 2009, 5:287.
74. Di Ventura B., et al. From in vivo to in silico biology and back. Nature 2006, 443:527-533.
75. Howe K., et al. In Silico and in Vitro Modeling of Hepatocyte Drug Transport Processes: Importance of ABCC2 Expression Levels in the Disposition of Carboxydichlorofluroscein. Drug Metabolism and Disposition 2009, 37:391-399.
76. Hewitt N.J., et al. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab. Rev. 2007, 39:159-234.
77. B. Naughton. Advanced Tissue Sciences Inc. Three Dimensional liver cell and tissue culture system, 5624840.
78. Sicklick J.K., et al. Hedgehog signaling maintains resident hepatic progenitors throughout life. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G859-870.
79. Demetriou A.A., et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 2004, 239:660-667. discussion 667-670.
80. Sung J.H., et al. Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling. Expert Opinion on Drug Metabolism & Toxicology 2010, 6:1063-1081.
81. Lemon G., et al. Mathematical modelling of tissue-engineered angiogenesis. Math Biosci. 2009, 221:101-120.
82. Calvert V.S., et al. A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology 2007, 46:166-172.
83. Chua K.N., et al. Stable immobilization of rat hepatocyte spheroids on galactosylated nanofiber scaffold. Biomaterials 2005, 26:2537-2547.
84. Ong S.M., et al. A gel-free 3D microfluidic cell culture system. Biomaterials 2008, 29:3237-3244.
85. Panseri S., et al. Electrospun micro- and nanofiber tubes for functional nervous regeneration in sciatic nerve transections. BMC Biotechnol. 2008, 8:39.
86. Qin D., et al. Soft lithography for micro- and nanoscale patterning. Nat. Protoc. 2010, 5:491-502.